TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive Congressional subcommittee criticizes NIH for lax conflict of interest policies. NIH Director Zerhouni promises change. The subcommittee has asked several NCI officials to testify at another hearing next week. May 14, 2004
TCL Archive Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development March 15, 1991
TCL Archive NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions. December 12, 2003
